TY - JOUR AU - Haffner, S. M. PY - 2000 DA - 2000// TI - Coronary heart disease in patients with diabetes JO - N Engl J Med VL - 342 UR - https://doi.org/10.1056/NEJM200004063421408 DO - 10.1056/NEJM200004063421408 ID - Haffner2000 ER - TY - JOUR AU - Miettinen, H. AU - Lehto, S. AU - Salomaa, V. AU - Mahonen, M. AU - Niemela, M. AU - Haffner, S. M. AU - Pyorala, K. AU - Tuomilehto, J. PY - 1998 DA - 1998// TI - Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group JO - Diabetes Care VL - 21 UR - https://doi.org/10.2337/diacare.21.1.69 DO - 10.2337/diacare.21.1.69 ID - Miettinen1998 ER - TY - JOUR AU - Haffner, S. M. AU - Lehto, S. AU - Ronnemaa, T. AU - Pyorala, K. AU - Laakso, M. PY - 1998 DA - 1998// TI - Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199807233390404 DO - 10.1056/NEJM199807233390404 ID - Haffner1998 ER - TY - JOUR PY - 2005 DA - 2005// TI - Standards of medical care in diabetes JO - Diabetes Care VL - 28 UR - https://doi.org/10.2337/diacare.28.suppl_1.S4 DO - 10.2337/diacare.28.suppl_1.S4 ID - ref4 ER - TY - CHAP AU - Giorda, C. AU - Nicolucci, A. PY - 2003 DA - 2003// BT - Diabete mellito di tipo 2. Complicanze e rischio cardiovascolare in Italia PB - Centro Scientifico Editore CY - Torino ID - Giorda2003 ER - TY - JOUR AU - Wald, N. J. AU - Law, M. R. PY - 2003 DA - 2003// TI - A strategy to reduce cardiovascular disease by more than 80% JO - BMJ VL - 326 UR - https://doi.org/10.1136/bmj.326.7404.1419 DO - 10.1136/bmj.326.7404.1419 ID - Wald2003 ER - TY - JOUR AU - Hippisley-Cox, J. AU - Coupland, C. PY - 2005 DA - 2005// TI - Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis JO - BMJ VL - 330 UR - https://doi.org/10.1136/bmj.330.7499.1059 DO - 10.1136/bmj.330.7499.1059 ID - Hippisley-Cox2005 ER - TY - JOUR AU - Evangelista, V. AU - Totani, L. AU - Rotondo, S. AU - Lorenzet, R. AU - Tognoni, G. AU - De Berardis, G. AU - Nicolucci, A. PY - 2005 DA - 2005// TI - Prevention of cardiovascular disease in type-2 diabetes: how to improve the clinical efficacy of aspirin JO - Thromb Haemost VL - 93 ID - Evangelista2005 ER - TY - JOUR PY - 2002 DA - 2002// TI - Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients JO - BMJ VL - 324 UR - https://doi.org/10.1136/bmj.324.7329.71 DO - 10.1136/bmj.324.7329.71 ID - ref9 ER - TY - JOUR AU - Sacco, M. AU - Pellegrini, F. AU - Roncaglioni, M. C. AU - Avanzini, F. AU - Tognoni, G. AU - Nicolucci, A. PY - 2003 DA - 2003// TI - Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial JO - Diabetes Care VL - 26 UR - https://doi.org/10.2337/diacare.26.12.3264 DO - 10.2337/diacare.26.12.3264 ID - Sacco2003 ER - TY - JOUR AU - Ridker, P. M. AU - Cook, N. R. AU - Lee, I. M. AU - Gordon, D. AU - Gaziano, J. M. AU - Manson, J. E. AU - Hennekens, C. H. AU - Buring, J. E. PY - 2005 DA - 2005// TI - A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women JO - N Engl J Med VL - 352 UR - https://doi.org/10.1056/NEJMoa050613 DO - 10.1056/NEJMoa050613 ID - Ridker2005 ER - TY - JOUR AU - Sciulli, M. G. AU - Renda, G. AU - Capone, M. L. AU - Tacconelli, S. AU - Ricciotti, E. AU - Manarini, S. AU - Evangelista, V. AU - Rebuzzi, A. AU - Patrignani, P. PY - 2006 DA - 2006// TI - Heterogeneity in the suppression of platelet cycloxigenase-1 activity by aspirin in coronary heart disease JO - Clin Pharmacol Ther VL - 80 UR - https://doi.org/10.1016/j.clpt.2006.04.011 DO - 10.1016/j.clpt.2006.04.011 ID - Sciulli2006 ER - TY - JOUR AU - Eikelboom, J. W. AU - Hirsh, J. AU - Weitz, J. I. AU - Johnston, M. AU - Yi, Q. AU - Yusuf, S. PY - 2002 DA - 2002// TI - Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events JO - Circulation VL - 105 UR - https://doi.org/10.1161/01.CIR.0000013777.21160.07 DO - 10.1161/01.CIR.0000013777.21160.07 ID - Eikelboom2002 ER - TY - JOUR AU - Halushka, M. K. AU - Halushka, P. V. PY - 2002 DA - 2002// TI - Why are some individuals resistant to the cardioprotective effects of aspirin? Could it be thromboxane A2? JO - Circulation VL - 105 UR - https://doi.org/10.1161/01.CIR.0000015422.86569.52 DO - 10.1161/01.CIR.0000015422.86569.52 ID - Halushka2002 ER - TY - JOUR AU - Ridker, P. M. PY - 2003 DA - 2003// TI - Clinical application of C-reactive protein for cardiovascular disease detection and prevention JO - Circulation VL - 107 UR - https://doi.org/10.1161/01.CIR.0000053730.47739.3C DO - 10.1161/01.CIR.0000053730.47739.3C ID - Ridker2003 ER - TY - JOUR AU - Steiner, M. AU - Reinhardt, K. M. AU - Krammer, B. AU - Ernst, B. AU - Blann, A. D. PY - 1994 DA - 1994// TI - Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control JO - Thromb Haemost VL - 72 ID - Steiner1994 ER - TY - JOUR AU - Otsuki, M. AU - Hashimoto, K. AU - Morimoto, Y. AU - Kishimoto, T. AU - Kasayama, S. PY - 1997 DA - 1997// TI - Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients JO - Diabetes VL - 46 UR - https://doi.org/10.2337/diab.46.12.2096 DO - 10.2337/diab.46.12.2096 ID - Otsuki1997 ER - TY - JOUR AU - Vinik, A. I. AU - Erbas, T. AU - Park, T. S. AU - Nolan, R. AU - Pittenger, G. L. PY - 2001 DA - 2001// TI - Platelet dysfunction in type 2 diabetes JO - Diabetes Care VL - 24 UR - https://doi.org/10.2337/diacare.24.8.1476 DO - 10.2337/diacare.24.8.1476 ID - Vinik2001 ER - TY - JOUR AU - Friend, M. AU - Vucenik, I. AU - Miller, M. PY - 2003 DA - 2003// TI - Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia JO - BMJ VL - 326 UR - https://doi.org/10.1136/bmj.326.7380.82 DO - 10.1136/bmj.326.7380.82 ID - Friend2003 ER - TY - JOUR AU - Albert, M. A. AU - Danielson, E. AU - Rifai, N. AU - Ridker, P. M. PY - 2001 DA - 2001// TI - Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study JO - JAMA VL - 286 UR - https://doi.org/10.1001/jama.286.1.64 DO - 10.1001/jama.286.1.64 ID - Albert2001 ER - TY - JOUR AU - Tan, K. C. AU - Chow, W. S. AU - Tam, S. C. AU - Ai, V. H. AU - Lam, C. H. AU - Lam, K. S. PY - 2002 DA - 2002// TI - Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus JO - J Clin Endocrinol Metab VL - 87 UR - https://doi.org/10.1210/jcem.87.2.8249 DO - 10.1210/jcem.87.2.8249 ID - Tan2002 ER - TY - JOUR AU - Liao, J. K. PY - 2002 DA - 2002// TI - Beyond lipid lowering: the role of statins in vascular protection JO - Int J Cardiol VL - 86 UR - https://doi.org/10.1016/S0167-5273(02)00195-X DO - 10.1016/S0167-5273(02)00195-X ID - Liao2002 ER - TY - JOUR AU - McFarlane, S. I. AU - Muniyappa, R. AU - Francisco, R. AU - Sowers, J. R. PY - 2002 DA - 2002// TI - Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond JO - J Clin Endocrinol Metab VL - 87 UR - https://doi.org/10.1210/jcem.87.4.8412 DO - 10.1210/jcem.87.4.8412 ID - McFarlane2002 ER - TY - JOUR AU - Hansson, L. AU - Hedner, T. AU - Dahlof, B. PY - 1992 DA - 1992// TI - Prospective randomized open blinded end-point (PROBE) Study. A novel desgin for intervention trials. Prospective Randomized Open Blinden End-Point JO - Blood Press VL - 1 UR - https://doi.org/10.3109/08037059209077502 DO - 10.3109/08037059209077502 ID - Hansson1992 ER - TY - JOUR PY - 2002 DA - 2002// TI - Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report JO - Circulation VL - 106 ID - ref25 ER - TY - JOUR AU - Vijan, S. AU - Hayward, R. A. PY - 2004 DA - 2004// TI - Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians JO - Ann Intern Med VL - 140 UR - https://doi.org/10.7326/0003-4819-140-8-200404200-00013 DO - 10.7326/0003-4819-140-8-200404200-00013 ID - Vijan2004 ER - TY - JOUR PY - 1994 DA - 1994// TI - Collaborative overview of randomised trials of antiplatelet therapy – I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients JO - BMJ VL - 308 UR - https://doi.org/10.1136/bmj.308.6921.81 DO - 10.1136/bmj.308.6921.81 ID - ref27 ER - TY - JOUR PY - 2002 DA - 2002// TI - MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20.536 high-risk individuals: a randomised placebo-controlled trial JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)09327-3 DO - 10.1016/S0140-6736(02)09327-3 ID - ref28 ER - TY - JOUR AU - de Gaetano, G. PY - 2001 DA - 2001// TI - Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project JO - Lancet VL - 357 UR - https://doi.org/10.1016/S0140-6736(00)04717-6 DO - 10.1016/S0140-6736(00)04717-6 ID - de Gaetano2001 ER - TY - JOUR AU - Peto, R. AU - Pike, M. C. AU - Armitage, P. AU - Breslow, N. E. AU - Cox, D. R. AU - Howard, S. V. AU - Mantel, N. AU - McPherson, K. AU - Peto, J. AU - Smith, P. G. PY - 1977 DA - 1977// TI - Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples JO - Br J Cancer VL - 35 UR - https://doi.org/10.1038/bjc.1977.1 DO - 10.1038/bjc.1977.1 ID - Peto1977 ER -